The DEEP project has received research funding from the European Union under the 7th Framework Programme

DEEP-3 – First patient enrolled!

DEEP-3 – First patient enrolled!

aprile 4, 2013
|
Comments off
|

On February 15th 2013 recruitment started for the DEEP-3 study (multi-centre, long-term observational safety study to evaluate the nature and incidence of adverse effects of deferiprone treatment in patients with beta-thalassaemia major aged from 1 month to less than 18 years). The first patient was enrolled at the ‘Agia Sofia’ Children’s Hospital, University of Athens in Greece.

Share